PTC THERAPEUTICS, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.7 | $0.8 | $0.9 | $0.7 | $0.5 |
| Operating income | $0.9 | -$0.3 | -$0.4 | -$0.4 | -$0.4 |
| Net income | $0.7 | -$0.4 | -$0.6 | -$0.6 | -$0.5 |
| Cash Flow Statement | |||||
| Free cash flow | $0.7 | -$0.1 | -$0.2 | -$0.4 | -$0.3 |
Shares outstanding 83.5M · Free float 94.7%
Annual filing data through FY ended December 31, 2025; float as of October 9, 2026.